Esperoct Prices, Coupons, Copay Cards & Patient Assistance
Esperoct (antihemophilic factor) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hemophilia A.
Esperoct prices
Intravenous Powder For Injection
exei recombinant glycopegylated Esperoct intravenous powder for injection from $12.85 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $12.85 | $12.85 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Esperoct Coupons, Copay Cards and Rebates
Esperoct offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Esperoct Co-pay Assistance Program
Eligible commercially insured patients may pay as little as $0 per fill with a maximum savings of $12,000 per calendar year.
- Applies to:
- Esperoct
- Number of uses:
- Per prescription per calendar year
Form more information phone: 844-668-6732 or Visit website
Esperoct Trial Prescription Program
Eligible commercially insured and uninsured patients may be eligible to receive a limited supply of free product.
- Applies to:
- Esperoct
- Number of uses:
- One-time offer
Form more information phone: 844-668-6732 or Visit website
Patient Assistance & Copay Programs for Esperoct
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Esperoct (turoctocog alfa pegol) Solution; IV
More information please phone: 866-316-7263 Visit website
Provider: Novo Nordisk Rare Bleeding Disorders Patient Assistance Program
Eligibility requirements:- Must be uninsured
- At or below 400% of FPL
- Medically appropriate condition/diagnosis
- The patient must be a US citizen or legal resident.
- Co-payment assistance, and patient assistance programs are available for eligible patients. Free Trial Program: Contact Program for details
- Esperoct (turoctocog alfa pegol) Solution; IV
More information please phone: 844-668-6732 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
DDAVP
DDAVP is used for diabetes insipidus, hemophilia a, primary nocturnal enuresis, von Willebrand Disease
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Altuviiio
Altuviiio is a once-weekly recombinant fact VIII replacement therapy used by hemophilia A patients ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Hemlibra
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that ...
Hympavzi
Hympavzi (marstacimab-hncq) may be used to prevent or reduce the frequency of bleeding episodes ...
More about Esperoct (antihemophilic factor)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Other brands
Altuviiio, Advate, Kovaltry, Xyntha, ... +14 more
Professional resources
- Esperoct prescribing information
- Antihemophilic Factor (recombinant), PEGylated-aucl (AHFS Monograph)
Other brands
Altuviiio, Advate, Kovaltry, Xyntha, ... +12 more